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Discussion
Dr Nicholas T. Kouchoukos (St Louis, Mo). Dr David and
his colleagues have presented important outcomes data for
212 patients who underwent the Ross procedure and have
been followed for a median of 12.8 years and for up to 20 years.
The significant positive findings include excellent long-term
survival, essentially equal to that for an age- and sex-matched
population, and extremely low rates of thromboembolism and
endocarditis.
The concerning findings relate to the need for reoperation on the
neo-aortic valve and progression of both aortic regurgitation and
pulmonary allograft dysfunction, both stenosis and regurgitation,
particularly in the second decade of follow-up, irrespective of
the need for reoperation. Although 82% of patients had not
required reoperation on the neo-aortic valve at 20 years, only
63% were free of more than mild aortic regurgitation at that
time interval. Similarly, although 93% had not required reopera-
tion on the pulmonary allograft at 20 years, only 54% were free
of either moderate or severe pulmonary valve regurgitation or
stenosis>40 mm Hg.
These important observations suggest that freedom from
reoperation is an inadequate predictor of successful outcome
after the Ross procedure. The rates of deterioration in function
of both the autograft and the allograft were substantially
greater in the second decade of follow-up when compared
with the first, and one can only speculate, because these
were relatively young patients, what will happen in the third
decade and beyond. The effects of these changes in valvular
function on overall cardiac performance were not reported
in this study but are of obvious importance when one is
considering the Ross procedure for a particular patient,
especially one who is young.The Journal of Thoracic and CAnother important issue is the technique of implantation of the
autograft. Your study demonstrated no difference in the need for
reoperation for neo-aortic valve regurgitation between the root
replacement and the subcoronary or root inclusion techniques.
However, they were performed for somewhat different indications.
Despite this difference, dilation of the aortic sinuses occurred
with both techniques, although at a higher rate with the root
replacement technique. You have speculated in the past that
reimplantation of the autograft within the aortic root may be
associated with better long-term outcomes. However, this was
not observed in your presentation today. I have several questions
and I will ask them separately.
External reinforcement techniques have been proposed and
used in an attempt to prevent aortic root dilation and regurgitation.
Is there a role for these modifications to reduce the frequency of
regurgitation and reoperation?
Dr Tirone E. David (Toronto, Ontario, Canada). I don’t
believe so. I did in the past, but as my experience has increased
it doesn’t look like the operative technique plays a role in the
failure of this operation. It is more a marker that certain patients
have. I believe that dilation of the aortic annulus is a marker
for connective tissue disorder, and we should avoid the Ross
procedure in these patients.
I should add that in our failures due to aortic insufficiency
we could not save the aortic valve. They all showed signs of
degenerative disease, indicating that, indeed, they are predestined
to fail under adverse conditions such as the systemic circulation.
Dr Kouchoukos. Dilation of the aortic root is not an infrequent
late occurrence and was present in 35 patients in your series. At
10 years, 25% of patients had dilation>4.5 cm. Dissection of
the dilated aortic root has been reported in a small number of
patients. Would you consider elective operation in patients who
have enlarged aortic roots, and if so, at what diameter?
Dr David. I no longer offer the Ross procedure to patients who
have an annulus>28 mm. I tell them that in our hands the failure
rate is pretty high and we prefer to use an alternative. Having said
that, for female patients in their childbearing years who do not
want a mechanical valve, the Ross is a reasonable alternative.
Perhaps those patients should have some sort of external
reinforcement, preferably their own aortic root. But in our
experience it is not the sinus that is the problem. The pulmonary
cusps fail when placed in the aortic position, suggesting that
annuloaortic ecstasia is a marker for something more serious
than a dysfunctional aortic valve.
Dr Kouchoukos. What do you do for those patients who have
developed dilation, with root 4.5 cm or greater?
Dr David.Most had a bicuspid aortic valve and an incompetent
valve at the time of the operation.
Dr Kouchoukos. When would you recommend elective
replacement of the enlarged root to avoid problems with further
enlargement or dissection? Ever?
Dr David. We used the same criteria for native aortic root
aneurysm; that is, recommend surgery when the diameter exceeds
50 mm. I don’t know if it is justifiable to operate earlier because
most of our patients who developed dilation of the neo-aortic
root had a dilated aortic annulus and they may have degenerative
changes in the cusps of the autograft precluding an aortic valve
sparing operation.ardiovascular Surgery c Volume 147, Number 1 93
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the Ross operation? If so, who do you consider to be an ideal
patient?
Dr David. A man with aortic stenosis and an annulus<28 mm.
In women, to be quite honest, the lesion doesn’t matter. I don’t
know why. In the 98 women we studied all have normally func-
tioning pulmonary valves at 20 years. In other words, any women
or young male patients with aortic stenosis and normal annulus.
Dr Gosta B. Pettersson (Cleveland, Ohio). I would like to ask
you about your choice of procedure for the reoperations. I noticed
that you had done only 1 reimplantation procedure. In the Ross
community there is a lot of enthusiasm for doing the reimplanta-
tion procedure for the reoperation to salvage the autograft in aortic
position. You also mentioned that the leaflets are not normal. I
agree with your observation, and, as you know, I have favored
the Ross reversal procedure as a way to salvage the autograft. So
my first question: What is your choice of reoperation procedure?
I also have a follow up question: Would you consider earlier
reoperation to salvage more autograft valves in aortic position
by reoperating earlier to have a better chance of being able to do
reimplantation?
DrDavid. In our cohort most had abnormal cusps at reoperation
that precluded an aortic valve sparing. Often 2 or 3 cusps were
torn, and the histology showed scar tissue and fragmentation of
the elastic, suggestive of a degenerative process. And because
they all came from patients with bicuspid aortic valve with dilated
aortic annulus, I have to make the assumption that it is unwise to
repair the cusps to save the autograft.
My experience is largely with bicuspid aortic valves. I don’t
have experience with rheumatic disease. They may behave
differently
Dr Pettersson. What do you think about the reverse Ross
operation?
Dr David. I commend you on that, as I know you have done it.
The Ross operation is a difficult operation. To reverse it must be
even more difficult. I imagine it can be done and I will try the
next time I reoperate on a failed Ross.
DrD. CraigMiller (Stanford, Calif). I did not hear an answer to
Nick’s specific question. At what size Ross root aneurysms when94 The Journal of Thoracic and Cardiovascular Surgedone as a root replacement do you recommend operation?
Has anyone ever seen a Ross root aneurysm rupture or dissect?
Dr David. I have never seen it. A friend showed me images of a
Ross with a root of 55 mm and the valve was fairly competent
because he had reinforced both the annulus and the sinotubular
junction, but the sinus ruptured and he had to operate on the patient
as an emergency.
DrMiller.When do you reoperate on patients who are dilating?
Dr David.At 50 mm because I am hoping to save the valve, but
I didn’t in most of them because of bad cusps.
Dr Miller. In your analysis you had 2 techniques, an inclusion
sleeve and a root replacement. Nearly half of your patients were
done in the proper way, a subcoronary scallop, the real way that
this operation was originally introduced, and Hans Sievers has
the best results in the world. Was that variable inspected in terms
of your 2 dependent outcome variables?
Dr David. The technique was not a predictor of reoperation or
aortic insufficiency. It was in an early analysis, but as the follow-up
increased, it doesn’t seem to be a predictor.
There are certain technical details of root replacement that are
the reason other surgeons encounter dilation and failure. Suturing
the autograft, with an annulus that is entirely muscular, in a
supra-annular position is doomed to fail. That annulus is going
to dilate. If you put the muscle inside the outflow tract where
nature made the native aortic annulus, I don’t believe it dilates
very much. So perhaps the outcomes have more to do with how
you perform the root replacement than with the subcoronary
versus root replacement technique.
Dr Miller. Did you examine the third technique, something
short of root replacement, in your statistical analysis, freehand
scalloped? Did you examine all 3 ways?
Dr David. No. We grouped them together because I performed
root inclusion more often than subcoronary. If the root was dilated
enough, I simply opened the noncoronary sinus down to the
annulus, put the pulmonary inside the native root, and closed it
either primarily or with a patch. That is my root inclusion
technique. I only use the subcoronary position in patients with
an entirely normal aortic annulus and sino-tubular junction, which
very few patients have.ry c January 2014
